Luminex, Prodesse, and BD Get FDA Warning Letters for H1N1 Flu Tests | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has sent warning letters to three diagnostics makers — Luminex, BD, and Prodesse — for marketing tests for the 2009 H1N1 Flu Virus, also known as the swine flu, that have not been cleared for marketing by the agency.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.